Harbor Medtech
Harbor MedTech, based in Irvine, offers innovative tissue regeneration products for chronic wounds, hernia, joint repair, and more.
Founded
2010Harbor MedTech, based in Irvine, offers innovative tissue regeneration products for chronic wounds, hernia, joint repair, and more.
Founded in Irvine, Harbor MedTech is a commercial-stage regenerative medicine company dedicated to developing and commercializing advanced tissue regeneration products. Their core mission is to deliver innovative solutions for chronic wounds, hernia, and joint repair using their patented BriDGE® technology. This technology transforms intact Type-I collagen into a bio-friendly matrix that activates the patient's healing process. Key products include NeuvoCell for chronic wounds, and Architect, a collagen matrix for skin wounds, addressing markets in diabetic, venous, and pressure ulcers, as well as orthopedic and urogynecological repairs.
Harbor MedTech has established strategic partnerships with notable entities like Edwards Lifesciences. The company has achieved significant milestones in both pre-clinical and clinical settings, demonstrating the efficacy of their BriDGE® technology. Their impact is evident in the improved outcomes for patients suffering from chronic and complex wounds, positioning Harbor MedTech as a leader in regenerative medicine.
Companies similar to Harbor Medtech include Histogen, Harvard Apparatus Regenerative Technology, bTECH and Tissue Regeneration.
Harbor Medtech was founded in 2010.
Harbor Medtech's headquarters is located in Irvine, CA, US.
As of Sep 5, 2017, Harbor Medtech has disclosed funding of $15.8M (USD). Undisclosed round amounts are excluded.
Harbor Medtech has 30 employees as of Feb 5, 2024.
Tissue Regeneration
